These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15320474)

  • 1. Therapeutic value of statins for vascular remodeling.
    Nagashima H; Kasanuki H
    Curr Vasc Pharmacol; 2003 Oct; 1(3):273-9. PubMed ID: 15320474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque.
    Morishita R; Tomita N; Ogihara T
    Curr Drug Targets; 2002 Oct; 3(5):379-85. PubMed ID: 12182229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering.
    Kolovou G
    Curr Med Res Opin; 2001; 17(1):34-7. PubMed ID: 11464443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statin therapy on vascular dysfunction.
    Aikawa M
    Coron Artery Dis; 2004 Aug; 15(5):227-33. PubMed ID: 15238817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review.
    Mihos CG; Salas MJ; Santana O
    Cardiol Rev; 2010; 18(6):298-304. PubMed ID: 20926939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and direct vascular actions.
    Mueck AO; Seeger H
    Panminerva Med; 2003 Mar; 45(1):1-6. PubMed ID: 12682615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
    Liao JK
    Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of statins, beyond lipid-lowering properties.
    Mihos CG; Pineda AM; Santana O
    Pharmacol Res; 2014 Oct; 88():12-9. PubMed ID: 24631782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
    Fujita R; Matsushima T
    Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
    Varughese GI; Patel JV; Lip GY; Varma C
    Curr Pharm Des; 2006; 12(13):1593-609. PubMed ID: 16729872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy.
    Mohajeri M; Banach M; Atkin SL; Butler AE; Ruscica M; Watts GF; Sahebkar A
    Trends Pharmacol Sci; 2018 Nov; 39(11):967-981. PubMed ID: 30249403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of pleiotropic effects of statins: lipid reduction and beyond.
    Auer J; Berent R; Weber T; Eber B
    Curr Med Chem; 2002 Oct; 9(20):1831-50. PubMed ID: 12369881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase.
    Kwok JM; Ma CC; Ma S
    Vascul Pharmacol; 2013 Jan; 58(1-2):21-30. PubMed ID: 23085091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.